Phoenix Holdings Ltd. Dexcom Inc Transaction History

Phoenix Holdings Ltd.

$6.66 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$110.31 - $140.45 $1.54 Million - $1.96 Million	-13,974 Reduced 88.49%	1,818 $206,000
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $36,778 - $45,112	322 Added 2.08%	15,792 $2.19 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $163,586 - $269,054	2,167 Added 16.29%	15,470 $1.92 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $164,546 - $263,722	-1,912 Reduced 12.57%	13,303 $1.24 Million
Q2 2023 Aug 07, 2023	BUY	$112.47 - $130.98 $299,057 - $348,275	2,659 Added 21.18%	15,215 $1.96 Million
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $513,760 - $607,224	4,940 Added 64.86%	12,556 $1.46 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $74,867 - $108,072	-881 Reduced 10.37%	7,616 $862,000
Q3 2022 Nov 10, 2022	SELL	$76.35 - $94.18 $218,819 - $269,919	-2,866 Reduced 25.22%	8,497 $1.05 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $599,603 - $1.17 Million	8,819 Added 346.66%	11,363 $847,000
Q1 2022 May 10, 2022	BUY	$94.08 - $130.2 $157,113 - $217,433	1,670 Added 191.08%	2,544 $1.3 Million
Q4 2021 Feb 07, 2022	SELL	$129.87 - $162.82 $24,415 - $30,610	-188 Reduced 17.7%	874 $472,000
Q3 2021 Oct 27, 2021	BUY	$106.71 - $143.18 $113,326 - $152,057	1,062 New	1,062 $578,000
Q2 2021 Aug 10, 2021	SELL	$80.99 - $107.93 $96,945 - $129,192	-1,197 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$84.79 - $104.74 $34,509 - $42,629	-407 Reduced 25.37%	1,197 $416,000
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $61,620 - $82,555	790 Added 97.05%	1,604 $580,000
Q3 2020 Nov 10, 2020	BUY	$95.51 - $112.95 $77,745 - $91,941	814 New	814 $309,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.

Account